X4 Pharmaceuticals, Inc - Common Stock, par value $0.001 per share (XFOR)

Historical Holders from Q1 2019 to Q3 2025

Symbol
XFOR on Nasdaq
CUSIP
98420X103
Type / Class
Equity / Common Stock, par value $0.001 per share
Shares outstanding
7.94M
All holders as of September 30, 2025
Q3 2025
Total 13F shares, excl. options
2.51M
Holdings value
$8.57M
% of all portfolios
0%
Grand Portfolio weight change
+0%
Number of holders
2
Number of buys
2
Average Value change %
+0%
Average buys %
+0%
Reported Shares, Excluding Options vs Price
Reported Value, Excluding Options
Total Investors

Significant Owners of X4 Pharmaceuticals, Inc - Common Stock, par value $0.001 per share (XFOR)

Filer Ownership Change % Holdings Value Net Change Nb Shares Change % Reporting Name Report Period
VANGUARD GROUP INC 4.8% $1.72M 8.2M The Vanguard Group Dec 31, 2024
ORBIMED ADVISORS LLC 1.7% $25.6K 135K ORBIMED ADVISORS LLC Jun 30, 2025

Institutional Holders of X4 Pharmaceuticals, Inc - Common Stock, par value $0.001 per share (XFOR)

Period Reported Shares, Excl. Options Value, Excl. Options Change Price Investors
2025 Q3 2.51M $8.57M +$6.34M $3.42 2
2025 Q2 653K $1.24M -$59.1M $1.90 2
2025 Q1 98.5M $23.3M -$1.45M $0.24 91
2024 Q4 99.8M $73.2M -$4.98M $0.73 89
2024 Q3 101M $67.3M -$551K $0.67 99
2024 Q2 102M $58.9M -$4.47M $0.58 99
2024 Q1 103M $143M +$8.94M $1.39 97
2023 Q4 49.3K $41.3K $0.84 1
2023 Q3 112M $123M -$3.79M $1.09 89
2023 Q2 113M $219M +$104M $1.94 94
2023 Q1 61M $53M +$698K $0.87 55
2022 Q4 60.6M $60.2M +$20.6M $0.99 50
2022 Q3 39.1M $66.8M +$39.5M $1.71 50
2022 Q2 16M $15.5M -$674K $0.97 42
2022 Q1 16.3M $28.6M -$2.24M $1.75 51
2021 Q4 17.6M $40.2M -$2.28M $2.29 49
2021 Q3 16.2M $85.7M -$2.79M $5.29 50
2021 Q2 16.6M $108M +$941K $6.50 60
2021 Q1 16.1M $139M +$48.9M $8.61 60
2020 Q4 9.74M $62.6M +$1.45M $6.43 51
2020 Q3 9.51M $64.4M -$4.9M $6.77 49
2020 Q2 10.7M $99.6M -$2.65M $9.32 53
2020 Q1 11.2M $112M +$1.38M $10.00 48
2019 Q4 11M $118M +$34.8M $10.70 52
2019 Q3 7.71M $98M +$1.6M $12.71 47
2019 Q2 7.58M $114M +$86.9M $15.00 42
2019 Q1 1.79M $31.1M +$31.1M $17.41 28